Skip to main content
ARTIVION, INC. logo

ARTIVION, INC. — Investor Relations & Filings

Ticker · AORT ISIN · US2289031005 LEI · 549300YTKV8DMSMG6K81 US Manufacturing
Open in API
Filings indexed 1,531 across all filing types
Latest filing 2023-02-21 Director's Dealing
Country US United States of America
Listing US AORT

About ARTIVION, INC.

https://artivion.com/

Artivion, Inc. is a medical device company focused on developing, manufacturing, and distributing solutions for cardiac and vascular surgery. The company has an intentional focus on creating technologies to treat diseases of the aorta. In collaboration with surgeons, Artivion develops products designed to address complex surgical challenges. Its portfolio includes a range of aortic-centric technologies, such as heart valve solutions, implantable human tissues (allografts), surgical sealants, and various stent grafts for the aortic arch, thoracoabdominal, abdominal, and peripheral aorta. The company's purpose is to provide simple, elegant solutions that improve surgical outcomes for patients with aortic diseases.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2023-02-21 English
FORM 4
Director's Dealing
2023-02-21 English
FORM 4
Director's Dealing
2023-02-21 English
FORM 4
Director's Dealing
2023-02-16 English
FORM 4
Director's Dealing
2023-02-16 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated February 16, 2023, for Artivion, Inc. It reports the issuance of a press release announcing financial results for the quarter ended December 31, 2022. The document explicitly states that the press release is attached as Exhibit 99.1 and that the information is "furnished" and not "filed." The content is a current report on Form 8-K, which is used for unscheduled material events or corporate changes. The document does not contain the full financial results or detailed financial statements itself but references the press release. This type of filing is best classified as a Regulatory Filing (RNS) because it is a current report providing regulatory disclosure but not a full earnings release or annual/interim report. The document length (5266 characters) and content support this classification rather than an Earnings Release (ER) or Interim Report (IR).
2023-02-16 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.